EU Pharma Denies Skirting Rules On Pediatric Cancer Drug Development
This article was originally published in The Pink Sheet Daily
Executive Summary
The European pharmaceutical industry has refuted claims that manufacturers are exploiting a loophole in EU legislation to avoid running non-lucrative trials for pediatric oncology drugs.